Edwards Lifesciences Corporation stock research
FY2025 Q1
Edwards Lifesciences (EW) Gross Margin — Quarter Ended Mar 31, 2025
Revenue was unchanged from the prior quarter, while cost of revenue increased, causing gross profit to remain flat and gross margin to decline slightly. Compared to the same quarter a year earlier, revenue and gross profit were higher, and gross margin improved.
Gross margin takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue was unchanged from the prior quarter, while cost of revenue increased, causing gross profit to remain flat and gross margin to decline slightly. Compared to the same quarter a year earlier, revenue and gross profit were higher, and gross margin improved.
- The gross margin declined slightly from the prior quarter as cost of revenue grew while revenue stayed flat; the filing notes the company's liquidity position but offers no specific margin commentary. Year-over-year, the margin improved as revenue growth outpaced cost growth.
- Gross margin was slightly lower than the prior quarter but higher than the same quarter one year earlier.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
78.7%
Gross profit
$1.1B
Revenue
$1.4B
Cost of revenue
$301.6M
Quarter-over-quarter change
-1.9 pts
Year-over-year change
+0.2 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Mar 31, 2024 | $1.3B | $1.0B | $286.9M | 78.4% |
| Jun 30, 2024 | $1.4B | $1.1B | $275.5M | 79.9% |
| Sep 30, 2024 | $1.4B | $1.1B | $262.9M | 80.6% |
| Mar 31, 2025 | $1.4B | $1.1B | $301.6M | 78.7% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Sep 30, 2024
-1.9 pts
Year-over-year change
Mar 31, 2024
+0.2 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
The gross margin declined slightly from the prior quarter as cost of revenue grew while revenue stayed flat; the filing notes the company's liquidity position but offers no specific margin commentary. Year-over-year, the margin improved as revenue growth outpaced cost growth.
Gross margin was slightly lower than the prior quarter but higher than the same quarter one year earlier.
Monitor the trend in cost of revenue relative to revenue, as any acceleration in cost growth could affect margins.